SecBot SecBot
SECBOTREPLAY Home › Report › RVPH

RVPH · Reviva Pharmaceuticals Holdings is implementing a 1-for-20 reverse…

REVIVA PHARMACEUTICALS HOLDINGS, INC. · 8-K filed Mar 5, 2026 at 08:02 ET

At the news

NEUTRALIMPACT 5/10

8-K filed Mar 5, 2026 at 08:02 ET

Reviva Pharmaceuticals Holdings is implementing a 1-for-20 reverse stock split effective March 9, 2026, to regain compliance with Nasdaq's $1.00 minimum bid price requirement after receiving a delisting notice. The reverse split aims to increase the stock price but may reduce liquidity and does not address underlying business fundamentals.

  • Company is executing a 1-for-20 reverse stock split effective March 9, 2026
  • Reverse split is intended to regain compliance with Nasdaq's $1.00 minimum bid price requirement
  • Company received Nasdaq delisting notice on May 13, 2025 for failing to maintain $1.00 minimum bid price
  • Nasdaq granted an exception period through March 27, 2026 to demonstrate compliance

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access